Hiroki Kobayashi

C-reactive protein and ground-glass opacity as predictors for intractable interstitial lung disease in patients with systemic sclerosis under cyclophosphamide treatment regardless of concomitant glucocorticoids.

S. Hirata, Y. Hosokawa, T. Tokunaga, 2021, Modern rheumatology.

Switching Treatment from Mepolizumab to Benralizumab for Elderly Patients with Severe Eosinophilic Asthma: A Retrospective Observational Study

H. Iwamoto, N. Hattori, N. Ishikawa, 2022, Internal medicine.

Systemic AL amyloidosis with high bone marrow plasma cells (BMPCs) infiltration: a case report and literature review

Wei Liu, M. Gertz, Hiroki Kobayashi, 2019, Journal of Xiangya Medicine.

The clinical characteristics and predictors of severe digital ischemia in patients with anti‐aminoacyl transfer RNA synthetase antibodies

Y. Matsuo, S. Hirata, Y. Hosokawa, 2021, The Journal of dermatology.

The Efficacy of Amenamevir for the Treatment of Disseminated Herpes Zoster Complicated with Probable Varicella-zoster Pneumonia in an Immunocompromised Patient

S. Hirata, Y. Hosokawa, Y. Yoshida, 2021, Internal medicine.

Efficacy of mepolizumab in elderly patients with severe asthma and overlapping COPD in real-world settings: A retrospective observational study.

H. Iwamoto, N. Hattori, N. Ishikawa, 2021, Respiratory investigation.